Al-Sawaf O, Jen M-H, Hess LM, Zhang J, Goebel B, Pagel JM, Abhyankar S, Davids MS, Eyre TA. Pirtobrutinib <i>versus</i> venetoclax in covalent Bruton tyrosine kinase inhibitor-pretreated chronic lymphocytic leukemia: a matching-adjusted indirect comparison. haematol [Internet]. 2024Jun.1 [cited 2024Jul.17];109(6):1866-73. Available from: https://haematologica.org/article/view/haematol.2023.284150